RecallRadar

FDA Drug recall D-613-2013

0.45% Sodium Chloride Injection, USP, Rx Only, 250 mL, by Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7132-02

On 2013-07-03 the FDA classified a Class II recall of 0.45% Sodium Chloride Injection, USP, Rx Only, 250 mL, by Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7132-02 by Hospira, citing lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possible leaking bags.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-613-2013
ClassificationClass II
Statusterminated
Initiated2012-05-04
Published2013-07-03
Last updated2026-09-13 11:51 UTC
CompanyHospira
DistributionUS

Product

0.45% Sodium Chloride Injection, USP, Rx Only, 250 mL, by Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7132-02

Reason

Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possible leaking bags.

Identifiers

ndc0409-7101-68
ndc0409-7101-66
ndc0409-7101-69
ndc0409-7101-67
ndc0409-7101-04
ndc0409-7101-02
ndc0409-7132-68
ndc0409-7132-66
ndc0409-7132-69
ndc0409-7132-67
ndc0409-7132-04
ndc0409-7132-02
code_infoLot #: 93-153-JT, Exp 9/12

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-613-2013%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.